Never miss an update from RAMOT at Tel Aviv University Ltd.
Create your free account to connect with RAMOT at Tel Aviv University Ltd. and thousands of other innovative organizations and professionals worldwide
A breakthrough Self Assembled Peptide Hydrogel (SAPH) has been developed. SAPH is a safe, self-assembled, biocompatible, remarkably strong hydrogel with modulated stability that is suitable for various medicinal and cosmetic applications
Project ID : 2-2007-14
The Technology
A breakthrough Self Assembled Peptide Hydrogel (SAPH) has been developed. SAPH is a safe, self-assembled, biocompatible, remarkably strong hydrogel with modulated stability that is suitable for various medicinal and cosmetic applications.
SAPH is based on the highly efficient self-assembly of the short aromatic peptides diphenylalanine. The discovery and development of SAPH is the current stage of world renown, ongoing research, led by Prof. Gazit and his team, back in 2001. The first finding of the research was that aromatic interactions play a pivotal role in the self-assembly process governing the biological fibril formation. This understanding had been translated not only to an extensive research on protein aggregation treatment, but also led to additional applications such as organic self-assembly nanotubes and the self-assembled hydrogel. SAPH is formed under mild conditions in aqueous solution and contains less than 1% peptide material; it's simple building blocks allow simple production process and chemical modifications capabilities allowing tailoring SAPH towards various needs. Aromatic interactions are also responsible for the remarkable rigidity displayed by SAPH, in spite of the short building block size. SAPH rigidity exceed those of known hydrogels, formed by much larger polypeptides .Biocompatible self-assembled Hydrogels such as SAPH are extremely crucial for a vast number of applications including tissue engineering and axonal regeneration, sustained drug release and cosmetic applications.
Potential Application
Stage of Development
Patents
Granted US patent US 7,786,086; PCT patent applications (WO2007/043048 and WO2011/151832).
Supporting Publications
Reches, M, & Gazit, E. (2003) Casting metal nanowires within discrete self-assembled peptide nanotubes. Science 300, 625-627.
Mahler, A., Reches, M., Rechter, M., Cohen, S., and Gazit, E. (2006) Novel Self-Assembled Gel Biomaterial Composed of Modified Aromatic Dipeptide. Adv. Mater. 18, 1365-1370. (Featured in an inside front cover).
Project manager
Rona Samler
VP, BD Physical Science, Medical Device, Chemistry
Project researchers
Zvi, Emeritus Nevo
T.A.U Tel Aviv University, Medicine-Sackler Faculty
Clinical Biochemistry
Ehud Gazit
T.A.U Tel Aviv University, Life Sciences
Molecular Microbiology-Biotechnology
Ramot is Tel Aviv University's (TAU) technology transfer company and its liaison to industry, bringing promising scientific discoveries made at the university to industry's attention. The company provides the legal and commercial frameworks for inventions made by TAU faculty, students and researchers, protecting discoveries with patents and working jointly with industry to bring scientific innovations to the market.
Create your free account to connect with RAMOT at Tel Aviv University Ltd. and thousands of other innovative organizations and professionals worldwide
Send a request for information
to RAMOT at Tel Aviv University Ltd.
Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.
Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support